JNJ

233.01

+1.03%↑

UNH

284.01

-0.6%↓

TMO

568.43

-2.07%↓

ABT

108.96

-0.46%↓

ISRG

478.71

-3.54%↓

JNJ

233.01

+1.03%↑

UNH

284.01

-0.6%↓

TMO

568.43

-2.07%↓

ABT

108.96

-0.46%↓

ISRG

478.71

-3.54%↓

JNJ

233.01

+1.03%↑

UNH

284.01

-0.6%↓

TMO

568.43

-2.07%↓

ABT

108.96

-0.46%↓

ISRG

478.71

-3.54%↓

JNJ

233.01

+1.03%↑

UNH

284.01

-0.6%↓

TMO

568.43

-2.07%↓

ABT

108.96

-0.46%↓

ISRG

478.71

-3.54%↓

JNJ

233.01

+1.03%↑

UNH

284.01

-0.6%↓

TMO

568.43

-2.07%↓

ABT

108.96

-0.46%↓

ISRG

478.71

-3.54%↓

Search

Simulations Plus Inc

Geschlossen

BrancheGesundheitswesen

15.31 -8.81

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

15.12

Max

16.67

Schlüsselkennzahlen

By Trading Economics

Einkommen

1.4M

676K

Verkäufe

961K

18M

KGV

Branchendurchschnitt

48.528

84.243

EPS

-0.034

Dividendenrendite

0.48

Gewinnspanne

3.67

Angestellte

212

EBITDA

-3M

2.3M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+13.3% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.48%

2.28%

Nächstes Ergebnis

2. Apr. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-30M

338M

Vorheriger Eröffnungskurs

24.12

Vorheriger Schlusskurs

15.31

Nachrichtenstimmung

By Acuity

34%

66%

95 / 352 Ranking in Healthcare

Simulations Plus Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

3. Feb. 2026, 23:11 UTC

Wichtige Markttreiber
Akquisitionen, Fusionen, Übernahmen

Silicon Laboratories Shares Up On Report of $7 Billion Texas Instruments Acquisition Deal

3. Feb. 2026, 23:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3. Feb. 2026, 23:50 UTC

Market Talk

Nikkei May Decline After Hitting All-Time High -- Market Talk

3. Feb. 2026, 23:42 UTC

Market Talk

Gold Edges Lower on Possible Technical Correction -- Market Talk

3. Feb. 2026, 23:41 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Makes AI Play With $10.9B Asia Data-Center Deal

3. Feb. 2026, 23:38 UTC

Ergebnisse

AMD Sales Climb on Help From Data-Center Business -- Update

3. Feb. 2026, 23:29 UTC

Akquisitionen, Fusionen, Übernahmen

KKR-Consortium Deal in STT GDC Is One of the Largest Digital-Infrastructure Transactions in Southeast Asia

3. Feb. 2026, 23:27 UTC

Akquisitionen, Fusionen, Übernahmen

Netflix, Warner Defend Proposed Deal in Senate Hearing -- WSJ

3. Feb. 2026, 23:25 UTC

Akquisitionen, Fusionen, Übernahmen

KKR-Consortium Expects Deal to Close by Early 2H of 2026

3. Feb. 2026, 23:23 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Consortium With Singtel to Own 75% and 25% Stake in ST Telemedia Global Data Centres

3. Feb. 2026, 23:22 UTC

Akquisitionen, Fusionen, Übernahmen

KKR-Led Consortium to Buy Singapore-Based Global Data-Center Provider Valued at S$13.8B

3. Feb. 2026, 23:19 UTC

Market Talk

Australia Gold Miners Tipped to Rally Higher -- Market Talk

3. Feb. 2026, 23:19 UTC

Market Talk

Global Equities Roundup: Market Talk

3. Feb. 2026, 22:56 UTC

Wichtige Markttreiber
Akquisitionen, Fusionen, Übernahmen

Silicon Laboratories Shares Up On Report of $7B Texas Instruments Acquisition Deal

3. Feb. 2026, 22:40 UTC

Ergebnisse

Amdocs Extends Collaboration With T-Mobile

3. Feb. 2026, 22:39 UTC

Ergebnisse

Amdocs 1Q Adj EPS $1.81

3. Feb. 2026, 22:39 UTC

Ergebnisse

Amdocs 1Q Rev $1.16B

3. Feb. 2026, 22:39 UTC

Ergebnisse

Amdocs 1Q EPS $1.45 >

3. Feb. 2026, 22:38 UTC

Ergebnisse

Amdocs: Shimie Hortig to Succeed Shuky Sheffer as President and CEO, Effective March 31

3. Feb. 2026, 22:30 UTC

Akquisitionen, Fusionen, Übernahmen

Bob Iger's Second Time as CEO Wasn't Great for the Stock. He Still Leaves Behind A Strong Legacy. -- Barrons.com

3. Feb. 2026, 22:22 UTC

Akquisitionen, Fusionen, Übernahmen

Texas Instruments Nearing $7B Deal for Silicon Laboratories, Sources Tell FT

3. Feb. 2026, 22:14 UTC

Ergebnisse

AMD Expects to Scale AI Business to Tens of Billions in Annual Sales in 2027, CEO Says

3. Feb. 2026, 22:13 UTC

Ergebnisse

AMD Expects Data-Center Unit Sales to Jump More Than 60% a Year Over Next Three to Five Years, CEO Says

3. Feb. 2026, 22:12 UTC

Ergebnisse

AMD in Talks With Several Companies About At-Scale, Multi-Year Chip Deployments, CEO Says

3. Feb. 2026, 22:10 UTC

Ergebnisse

AMD CEO: Eight of 10 Biggest AI Companies Use Instinct Chip to Power Production Workloads

3. Feb. 2026, 22:10 UTC

Ergebnisse

Blackstone Stock, Alternative Managers, BDCs Dive as Software Woes Infect Private Credit -- Barrons.com

3. Feb. 2026, 22:10 UTC

Market Talk

Key Drivers Underpinning Shaw's Bullish View of Gold Intact -- Market Talk

3. Feb. 2026, 22:10 UTC

Ergebnisse

AMD CEO: Enterprises Are Modernizing Data Centers to Have Compute Needed for New AI Workflows

3. Feb. 2026, 22:09 UTC

Ergebnisse

AMD CEO: Hyperscalers Expanding Infrastructure to Meet Growing Cloud-Services Demand in AI

3. Feb. 2026, 22:09 UTC

Ergebnisse

AMD CEO: Demand Accelerated Across Data Center, Gaming and PC

Peer-Vergleich

Kursveränderung

Simulations Plus Inc Prognose

Kursziel

By TipRanks

13.3% Vorteil

12-Monats-Prognose

Durchschnitt 19 USD  13.3%

Hoch 19 USD

Tief 19 USD

Basierend auf 4 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Simulations Plus Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

4 ratings

2

Buy

2

Halten

0

Sell

Stimmung

By Acuity

95 / 352 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Simulations Plus Inc

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
help-icon Live chat